Delivery Order SPE2DB22D3011-SPE2DB25FQ2ML
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Chlorhexidine 0.12% in 15 milliliter unit dose cups, with a ceiling value of $1,526.10 and ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under the company's broader contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,017.40 to AmerisourceBergen Drug Corp for the supply of Chlorhexidine 0.12% in 15 milliliter unit dose cups on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $2,748.51 delivery order to AmerisourceBergen Drug Corp for the supply of Chlorhexidine 0.12% Rinse in 473ml quantities. This competitive award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price transaction with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Chlorhexidine 0.12% Rinse 473ML. The $1,171.76 Firm Fixed Price contract has an ultimate completion date of July 19, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $42,288.33 to AmerisourceBergen Drug Corp on August 27, 2025, for pharmaceutical products and medical supplies. This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and runs through December 2026. The delivery order will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $16,222.44 to AmerisourceBergen Drug Corp under a firm fixed-price contract with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded delivery order represents a discrete task order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,594.24 to AmerisourceBergen Drug Corp on August 19, 2025, with completion anticipated by August 20, 2025. This firm fixed-price delivery order, issued under a competitive procurement with no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,740.00 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor for pharmaceutical products and medical supplies. The contract work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,169.99 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The award is being fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, and the specific...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2MLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,089.30 to AmerisourceBergen Drug Corp for the supply of Chlorhexidine 0.12% in 15 milliliter unit-dose cups. This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, medical devices, and specialized healthcare commodities. The company's consistent receipt of competitively awarded contracts across multiple therapeutic domains demonstrates its established capacity to fulfill federal medical procurement requirements for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/29/25 |